Published in
Springer, Investigational New Drugs, 2(36), p. 288-298, 2017
DOI: 10.1007/s10637-017-0555-8
Links
Tools
A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer
Journal article published in 2017 by
Muhammad Alamgeer 
,
D. Neil Watkins,
Ilia Banakh,
Beena Kumar,
Daniel J. Gough ,
Ben Markman,
Vinod Ganju
,
D. Neil Watkins,
Ilia Banakh,
Beena Kumar,
Daniel J. Gough ,
Ben Markman,
Vinod Ganju
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 